Balchem's Stellar Q2 Performance.
Balchem Posts Record Q2 2026 Results, Driven by Robust Segment Growth and Volume Gains.
Anonymous
Key Points
1
European monogastric business realized higher volumes and margins following the implementation of EU antidumping duties, which restored a level playing field.
2
Animal Nutrition & Health (ANH) posted margin improvement and about 15% sales growth, aided by the adoption of encapsulated rumen-protected technologies in the dairy market.
3
Balchem refinanced its revolving credit facility, increasing capacity to $650 million and extending maturity.
4
Balchem's stock traded around $164 after the results, with a 52-week range of $139.17 to $183.90 and a session uptick of about 0.86%.
5
Future growth in the ruminant portfolio is expected to be driven by volume as the company continues to build science-based awareness for its precision-release technologies.
Balmer Lawrie & Co. Ltd. posted stronger sales for the first quarter ended June 30, 2026, with revenue climbing to INR 7,487.32 million from INR 6,806.58 million a year ago, according to MarketScreener. That marks a year-over-year gain of roughly 10%, signaling steady momentum for the Indian government-owned industrial conglomerate.
Sales Jump 10% as Revenue Crosses INR 7.4 Billion
Balmer Lawrie reported Q1 FY2026 sales of INR 7,487.32 million, up from INR 6,806.58 million in the same quarter last year, MarketScreener reported. The roughly INR 681 million increase reflects broad-based operational improvement across the company's diverse business segments. The results cover the April–June 2026 quarter.
The company operates across multiple sectors, including logistics infrastructure, industrial packaging, lubricants, and travel services. The revenue growth suggests demand held firm across several of these verticals during the quarter, though a detailed segment-by-segment breakdown was not immediately available from the earnings release.
A Brief Note on Balchem's Separate Record Quarter
Separately, U.S. specialty chemicals firm Balchem Corporation reported record Q2 2026 results, with sales of $284.0 million — up 11.2% — and adjusted EBITDA of $77.9 million, up 12.6%, according to Yahoo Finance. Adjusted earnings per share rose 17.3% to $1.49, beating analyst expectations. Balchem's stock traded near $164 after the results.
Balchem highlighted 28 consecutive quarters of year-over-year adjusted EBITDA growth. All three of its segments — Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products — contributed to the gains, GuruFocus noted. The company also refinanced its revolving credit facility, raising capacity to $650 million.
Balmer Lawrie's Track Record and Government Ownership
Balmer Lawrie is a public sector undertaking under India's Ministry of Petroleum and Natural Gas. It has a long operating history and runs businesses ranging from steel drum manufacturing to cold chain logistics. The company's Q1 revenue figure of INR 7,487.32 million compares favorably to the prior year's INR 6,806.58 million, per MarketScreener.
Full profit figures — including net income and earnings per share — were not detailed in the initial earnings release summaries. Investors are expected to watch for additional disclosures from the company's board and regulatory filings to assess margin trends and segment-level performance for the quarter.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
13
Articles
34
Reach
47
A
AnonymousAuthor